HEADER LIGASE 12-JUL-06 2DTH TITLE THE CRYSTAL STRUCTURE OF THE ORTHORHOMBIC FORM OF BIOTIN PROTEIN TITLE 2 LIGASE FROM PYROCOCCUS HORIKOSHII OT3 IN COMPLEX WITH BIOTIN AND ADP COMPND MOL_ID: 1; COMPND 2 MOLECULE: 235AA LONG HYPOTHETICAL BIOTIN--[ACETYL-COA-CARBOXYLASE] COMPND 3 LIGASE; COMPND 4 CHAIN: A, B; COMPND 5 SYNONYM: BIOTIN PROTEIN LIGASE; COMPND 6 EC: 6.3.4.15; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PYROCOCCUS HORIKOSHII; SOURCE 3 ORGANISM_TAXID: 70601; SOURCE 4 STRAIN: OT3; SOURCE 5 GENE: BIRA; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: (DE3)RIL; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET 11A KEYWDS BIOTIN BIOSYNTHESIS, DIMER, STRUCTURAL GENOMICS, NPPSFA, NATIONAL KEYWDS 2 PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN KEYWDS 3 STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, LIGASE EXPDTA X-RAY DIFFRACTION AUTHOR B.BAGAUTDINOV,N.KUNISHIMA,RIKEN STRUCTURAL GENOMICS/PROTEOMICS AUTHOR 2 INITIATIVE (RSGI) REVDAT 4 25-OCT-23 2DTH 1 REMARK REVDAT 3 13-JUL-11 2DTH 1 VERSN REVDAT 2 24-FEB-09 2DTH 1 VERSN REVDAT 1 12-JAN-07 2DTH 0 JRNL AUTH B.BAGAUTDINOV,N.KUNISHIMA JRNL TITL LIGAND STRUCTURES OF BIOTIN PROTEIN LIGASE FROM PYROCOCCUS JRNL TITL 2 HORIKOSHII OT3 JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 36.24 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.6 REMARK 3 NUMBER OF REFLECTIONS : 38943 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.240 REMARK 3 FREE R VALUE : 0.269 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1940 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.95 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.02 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.80 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2610 REMARK 3 BIN FREE R VALUE : 0.2970 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 193 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.021 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3674 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 66 REMARK 3 SOLVENT ATOMS : 611 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 26.22 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.61000 REMARK 3 B22 (A**2) : 7.14000 REMARK 3 B33 (A**2) : -2.52000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.26 REMARK 3 ESD FROM SIGMAA (A) : 0.17 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.30 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.20 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.200 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.90 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.810 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : OVERALL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2DTH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 14-JUL-06. REMARK 100 THE DEPOSITION ID IS D_1000025823. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-JUN-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL26B1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS V REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38943 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.950 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 200 DATA REDUNDANCY : 5.500 REMARK 200 R MERGE (I) : 0.12400 REMARK 200 R SYM (I) : 0.09700 REMARK 200 FOR THE DATA SET : 7.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.95 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.02 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.3 REMARK 200 DATA REDUNDANCY IN SHELL : 5.90 REMARK 200 R MERGE FOR SHELL (I) : 0.48600 REMARK 200 R SYM FOR SHELL (I) : 0.39500 REMARK 200 FOR SHELL : 4.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: 2FYK REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.56 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.54 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG20K, ACETATE, NAOH, 2.5MM ADP, REMARK 280 2.5MM BIOTIN, 1MM MNCL2, PH 5.2, MICROBATCH, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 35.00050 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 52.10500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.35900 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 52.10500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 35.00050 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 36.35900 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL UNIT IS A DIMER IDENTICAL TO THE ASYMMETRIC REMARK 300 UNIT REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3090 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20970 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -1.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 8 -66.16 -123.95 REMARK 500 LYS A 27 -69.12 -92.94 REMARK 500 THR A 28 7.23 -55.72 REMARK 500 LYS A 120 34.07 -153.67 REMARK 500 VAL A 132 -78.05 -114.96 REMARK 500 ASP A 206 -172.39 179.35 REMARK 500 ASP A 209 6.88 -68.75 REMARK 500 ILE B 8 -63.82 -120.78 REMARK 500 VAL B 132 -76.15 -112.22 REMARK 500 ASP B 206 179.16 176.54 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 ADP A 1301 REMARK 610 ADP B 1302 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ADP A 1301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ADP B 1302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BTN A 1401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BTN B 1402 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1WNL RELATED DB: PDB REMARK 900 THE SAME PROTEIN IN THE MONOCLINIC FORM REMARK 900 RELATED ID: 1WPY RELATED DB: PDB REMARK 900 THE SAME PROTEIN IN THE MONOCLINIC FORM REMARK 900 RELATED ID: 1WQ7 RELATED DB: PDB REMARK 900 THE SAME PROTEIN IN THE MONOCLINIC FORM REMARK 900 RELATED ID: 1WQW RELATED DB: PDB REMARK 900 THE SAME PROTEIN IN THE MONOCLINIC FORM REMARK 900 RELATED ID: 1X01 RELATED DB: PDB REMARK 900 THE SAME PROTEIN IN THE MONOCLINIC FORM REMARK 900 RELATED ID: 2FYK RELATED DB: PDB REMARK 900 THE SAME PROTEIN IN THE MONOCLINIC FORM REMARK 900 RELATED ID: PHO001000147.11 RELATED DB: TARGETDB DBREF 2DTH A 1 235 UNP O57883 O57883_PYRHO 1 235 DBREF 2DTH B 1 235 UNP O57883 O57883_PYRHO 1 235 SEQRES 1 A 235 MET LEU GLY LEU LYS THR SER ILE ILE GLY ARG ARG VAL SEQRES 2 A 235 ILE TYR PHE GLN GLU ILE THR SER THR ASN GLU PHE ALA SEQRES 3 A 235 LYS THR SER TYR LEU GLU GLU GLY THR VAL ILE VAL ALA SEQRES 4 A 235 ASP LYS GLN THR MET GLY HIS GLY ARG LEU ASN ARG LYS SEQRES 5 A 235 TRP GLU SER PRO GLU GLY GLY LEU TRP LEU SER ILE VAL SEQRES 6 A 235 LEU SER PRO LYS VAL PRO GLN LYS ASP LEU PRO LYS ILE SEQRES 7 A 235 VAL PHE LEU GLY ALA VAL GLY VAL VAL GLU THR LEU LYS SEQRES 8 A 235 GLU PHE SER ILE ASP GLY ARG ILE LYS TRP PRO ASN ASP SEQRES 9 A 235 VAL LEU VAL ASN TYR LYS LYS ILE ALA GLY VAL LEU VAL SEQRES 10 A 235 GLU GLY LYS GLY ASP LYS ILE VAL LEU GLY ILE GLY LEU SEQRES 11 A 235 ASN VAL ASN ASN LYS VAL PRO ASN GLY ALA THR SER MET SEQRES 12 A 235 LYS LEU GLU LEU GLY SER GLU VAL PRO LEU LEU SER VAL SEQRES 13 A 235 PHE ARG SER LEU ILE THR ASN LEU ASP ARG LEU TYR LEU SEQRES 14 A 235 ASN PHE LEU LYS ASN PRO MET ASP ILE LEU ASN LEU VAL SEQRES 15 A 235 ARG ASP ASN MET ILE LEU GLY VAL ARG VAL LYS ILE LEU SEQRES 16 A 235 GLY ASP GLY SER PHE GLU GLY ILE ALA GLU ASP ILE ASP SEQRES 17 A 235 ASP PHE GLY ARG LEU ILE ILE ARG LEU ASP SER GLY GLU SEQRES 18 A 235 VAL LYS LYS VAL ILE TYR GLY ASP VAL SER LEU ARG PHE SEQRES 19 A 235 LEU SEQRES 1 B 235 MET LEU GLY LEU LYS THR SER ILE ILE GLY ARG ARG VAL SEQRES 2 B 235 ILE TYR PHE GLN GLU ILE THR SER THR ASN GLU PHE ALA SEQRES 3 B 235 LYS THR SER TYR LEU GLU GLU GLY THR VAL ILE VAL ALA SEQRES 4 B 235 ASP LYS GLN THR MET GLY HIS GLY ARG LEU ASN ARG LYS SEQRES 5 B 235 TRP GLU SER PRO GLU GLY GLY LEU TRP LEU SER ILE VAL SEQRES 6 B 235 LEU SER PRO LYS VAL PRO GLN LYS ASP LEU PRO LYS ILE SEQRES 7 B 235 VAL PHE LEU GLY ALA VAL GLY VAL VAL GLU THR LEU LYS SEQRES 8 B 235 GLU PHE SER ILE ASP GLY ARG ILE LYS TRP PRO ASN ASP SEQRES 9 B 235 VAL LEU VAL ASN TYR LYS LYS ILE ALA GLY VAL LEU VAL SEQRES 10 B 235 GLU GLY LYS GLY ASP LYS ILE VAL LEU GLY ILE GLY LEU SEQRES 11 B 235 ASN VAL ASN ASN LYS VAL PRO ASN GLY ALA THR SER MET SEQRES 12 B 235 LYS LEU GLU LEU GLY SER GLU VAL PRO LEU LEU SER VAL SEQRES 13 B 235 PHE ARG SER LEU ILE THR ASN LEU ASP ARG LEU TYR LEU SEQRES 14 B 235 ASN PHE LEU LYS ASN PRO MET ASP ILE LEU ASN LEU VAL SEQRES 15 B 235 ARG ASP ASN MET ILE LEU GLY VAL ARG VAL LYS ILE LEU SEQRES 16 B 235 GLY ASP GLY SER PHE GLU GLY ILE ALA GLU ASP ILE ASP SEQRES 17 B 235 ASP PHE GLY ARG LEU ILE ILE ARG LEU ASP SER GLY GLU SEQRES 18 B 235 VAL LYS LYS VAL ILE TYR GLY ASP VAL SER LEU ARG PHE SEQRES 19 B 235 LEU HET ADP A1301 17 HET BTN A1401 16 HET ADP B1302 17 HET BTN B1402 16 HETNAM ADP ADENOSINE-5'-DIPHOSPHATE HETNAM BTN BIOTIN FORMUL 3 ADP 2(C10 H15 N5 O10 P2) FORMUL 4 BTN 2(C10 H16 N2 O3 S) FORMUL 7 HOH *611(H2 O) HELIX 1 1 SER A 21 THR A 28 1 8 HELIX 2 2 PRO A 71 PRO A 76 5 6 HELIX 3 3 LYS A 77 PHE A 93 1 17 HELIX 4 4 SER A 142 GLY A 148 1 7 HELIX 5 5 PRO A 152 ASN A 174 1 23 HELIX 6 6 MET A 176 MET A 186 1 11 HELIX 7 7 SER B 21 SER B 29 1 9 HELIX 8 8 GLY B 47 ARG B 51 5 5 HELIX 9 9 ASP B 74 PRO B 76 5 3 HELIX 10 10 LYS B 77 PHE B 93 1 17 HELIX 11 11 SER B 142 GLY B 148 1 7 HELIX 12 12 PRO B 152 ASN B 174 1 23 HELIX 13 13 ASP B 177 ASP B 184 1 8 SHEET 1 A14 ARG A 98 LYS A 100 0 SHEET 2 A14 ASP A 104 VAL A 107 -1 O LEU A 106 N ARG A 98 SHEET 3 A14 LYS A 110 GLY A 119 -1 O ILE A 112 N VAL A 105 SHEET 4 A14 ILE A 124 LEU A 130 -1 O VAL A 125 N GLU A 118 SHEET 5 A14 LEU A 60 LEU A 66 -1 N LEU A 66 O ILE A 124 SHEET 6 A14 VAL A 36 GLN A 42 -1 N ILE A 37 O SER A 63 SHEET 7 A14 ARG A 12 ILE A 19 1 N ILE A 14 O VAL A 36 SHEET 8 A14 ARG B 12 ILE B 19 -1 O TYR B 15 N VAL A 13 SHEET 9 A14 VAL B 36 GLN B 42 1 O VAL B 36 N ILE B 14 SHEET 10 A14 LEU B 60 LEU B 66 -1 O SER B 63 N ILE B 37 SHEET 11 A14 LYS B 123 LEU B 130 -1 O ILE B 124 N LEU B 66 SHEET 12 A14 LYS B 110 LYS B 120 -1 N LEU B 116 O GLY B 127 SHEET 13 A14 ASP B 104 VAL B 107 -1 N VAL B 107 O LYS B 110 SHEET 14 A14 ARG B 98 LYS B 100 -1 N ARG B 98 O LEU B 106 SHEET 1 B 5 VAL A 222 VAL A 225 0 SHEET 2 B 5 LEU A 213 ARG A 216 -1 N ILE A 215 O LYS A 223 SHEET 3 B 5 SER A 199 ILE A 207 -1 N ASP A 206 O ILE A 214 SHEET 4 B 5 ARG A 191 LEU A 195 -1 N VAL A 192 O GLY A 202 SHEET 5 B 5 SER A 231 PHE A 234 -1 O ARG A 233 N LYS A 193 SHEET 1 C 5 VAL B 222 VAL B 225 0 SHEET 2 C 5 LEU B 213 ARG B 216 -1 N LEU B 213 O VAL B 225 SHEET 3 C 5 SER B 199 ILE B 207 -1 N ASP B 206 O ILE B 214 SHEET 4 C 5 ARG B 191 LEU B 195 -1 N VAL B 192 O GLY B 202 SHEET 5 C 5 SER B 231 PHE B 234 -1 O ARG B 233 N LYS B 193 CISPEP 1 TRP A 101 PRO A 102 0 0.05 CISPEP 2 TRP B 101 PRO B 102 0 0.16 SITE 1 AC1 10 ARG A 51 LYS A 52 TRP A 53 GLU A 54 SITE 2 AC1 10 LYS A 111 ASN A 131 ALA A 140 HOH A1451 SITE 3 AC1 10 HOH A1616 PRO B 71 SITE 1 AC2 7 ARG B 51 LYS B 52 TRP B 53 GLU B 54 SITE 2 AC2 7 ASN B 131 ALA B 140 HOH B1700 SITE 1 AC3 17 SER A 21 THR A 22 ASN A 23 GLN A 42 SITE 2 AC3 17 GLY A 45 HIS A 46 GLY A 47 ARG A 48 SITE 3 AC3 17 TRP A 53 LEU A 62 ASN A 103 ASP A 104 SITE 4 AC3 17 LYS A 111 GLY A 114 VAL A 115 ILE A 128 SITE 5 AC3 17 GLY A 129 SITE 1 AC4 16 SER B 21 THR B 22 ASN B 23 GLN B 42 SITE 2 AC4 16 GLY B 45 HIS B 46 GLY B 47 ARG B 48 SITE 3 AC4 16 LEU B 62 ASN B 103 ASP B 104 LYS B 111 SITE 4 AC4 16 GLY B 114 VAL B 115 ILE B 128 GLY B 129 CRYST1 70.001 72.718 104.210 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014286 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013752 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009596 0.00000